In the present study, the overexpression of Meis2 can attenuate the stemness of GC cells, which was characterized as the alteration of stem cell markers and the ratio of CD44+ subpopulation with stemness, as well as the size and number of GC cells. This evidence concerns the gene MEIS2 and gastric cancer.